Surgical approach in patients with hyperparathyroidism in multiple endocrine neoplasia type 1: Total versus partial parathyroidectomy

Clinics

Volumn 67, Issue SUPPLEMENT, 2012, Pages 155-160

  Tonelli, Francesco ^a   Giudici, Francesco ^a   Cavalli, Tiziana ^a   Brandi, Maria Luisa ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

MEN1; Primary hyperparathyroidism; Subtotal parathyroidectomy; Surgery; Total parathyroidectomy

Indexed keywords

PARATHYROID HORMONE;

HUMAN; METHODOLOGY; MULTIPLE ENDOCRINE NEOPLASIA; PARATHYROIDECTOMY; PATHOLOGY; PEROPERATIVE CARE; PREOPERATIVE CARE; PRIMARY HYPERPARATHYROIDISM; RECURRENT DISEASE; REVIEW; STATISTICS; THYROID GLAND;

HUMANS; HYPERPARATHYROIDISM, PRIMARY; INTRAOPERATIVE CARE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PARATHYROID HORMONE; PARATHYROIDECTOMY; PREOPERATIVE CARE; RECURRENCE; THYROID GLAND;

EID: 84863902957     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2012(Sup01)26     Document Type: Review

References (49)

1. Marx SJ, Simonds WF, Agarwal SK, Burns AL, Weinstein LS, Cochran C, et al. Hyperparathyroidism in hereditary syndromes: special expression and special managements. J Bone Miner Res. 2002;17(Suppl 2):37-43.
2. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, et al. Guidelines for diagnosis and therapy of MEN type1 and type2. J Clin Endocrinol Metab. 2001;86(12):5658-71, http://dx.doi.org/10.1210/jc.86.12.5658.
3. Marx SJ, Menczel J, Campbell, Aurbach GD, Spiegel AM, Norton JA. Heterogeneous size of the parathyroid glands in familial multiple endocrine neoplasia type 1. Clin Endocrinol. 1991;35(6):521-6, http://dx.doi.org/10.1111/j.1365-2265.1991.tb00938.x.
4. Arnalsteen LC, Alesina PF, Quireux JL, Farrel SG, Patton FN, Carnaille BM, et al. Long-term results of less than total parathyroidectomy for hyperparathyroidism in multiple endocrine neoplasia type 1. Surgery. 2002;132(6):1119-25, http://dx.doi.org/10.1067/msy.2002.128607.
5. Kraimps JL, Quan-Yang Duh, Demeure M, Clark OH. Hyperparathyroidism in multiple endocrine neoplasia syndrome. Surgery. 1992;112(6):1080-8.
6. Tonelli F, Marcucci T, Fratini G, Tommasi MS, Falchetti A, Brandi ML. Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple endocrine neoplasia type 1? Ann Surg. 2007;246(6):1075-82, http://dx.doi.org/10.1097/SLA.0b013e31811f4467.
7. Henry JF, Defechereux T, Raffaelli M, Lubrano D, Iacobone M. Supernumerary ectopic hyperfunctioning parathyroid gland: a potential pitfall in surgery for sporadic primary hyperparathyroidism. Ann Chir. 2000;125(3):247-52, http://dx.doi.org/10.1016/S0003-3944(00)00247-9.
8. Wang CA. The anatomic basis of parathyroid surgery. Ann Surg 1976;183(3):271-5.
9. Akerstrom G, Malmaeus J, Bergstrom R. Surgical anatomy of human parathyroid glands. Surgery. 1984;95(1):14-21.
10. Aly A, Douglas M. Embryonic parathyroid rests occur commonly and have implications in the management of secondary hyperparathyroidism. ANZ J Surg. 2003;73(5):284-8, http://dx.doi.org/10.1046/j.1445-2197.2003.t01-1-02620.x.
11. Kollmorgen CF, Aust MR, Ferreiro JA, McCarthy JT, van Heerden JA. Parathyromatosis: a rare yet important cause of persistent or recurrent hyperparathyroidism. Surgery. 1994;116(1):111-5.
12. Burgess JR, David R, Greenaway TM, Parameswaran V, Shepherd JJ. Osteoporosis in multiple endocrine neoplasia type1. Arch Surg. 1999;134(10):1119-23, http://dx.doi.org/10.1001/archsurg.134.10.1119.
13. Norton JA, Venzon DJ, Berna MJ, Alexander HR, Fraker DL, Libutti SK, et al. Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT. Ann Surg. 2008;247(3):501-10, http://dx.doi.org/10.1097/SLA.0b013e31815 efda5.
14. Goudet P, Cougard P, Vergès B Murat A, Carnaille B, Calender A, et al. Hyperparathyroidism in multiple endocrine neoplasia type I: surgical trends and results of a 256-patient series from groupe d'etude des nèoplasies endocriniennes multiples study group. World J Surg. 2001;25(7):886-90, http://dx.doi.org/10.1007/s00268-001-0046-z.
15. O' Riordain DS, O' Brian T, Grant CS, Weaver A, Gharib H, van Heerden JA. Surgical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1 and 2. Surgery. 1993;114(6):1031-9.
16. Sokol MS, Kavolius J, Schaaf M, D'Avis J. Recurrent hyperparathyroidism from benign neoplastic seeding: A review with recommendations for management. Surgery. 1993;113(4):456-61.
17. Hellman P, Skogseid B, Juhlin C, Akerström G, Rastad J. Findings and long-term results of parathyroid surgery in multiple endocrine neoplasia type 1. World J Surg. 1992;16(4):718-25, http://dx.doi.org/10.1007/BF02067367.
18. Janson S, Tisell LE. Total parathyroidectomy and parathyroid transplantation into subcutaneous fat tissue in the treatment of hyperparathyroidism in multiple endocrine neoplasia type 1. Acta Chir Austriaca. 1994;26 (Suppl.112):23-6.
19. Nilsson O, Ahlman H, Tisell LE. Autotransplantation of parathyroid tissue into subcutaneous fat in the treatment of hyperparathyroidism in MEN-1. Abstracts of the Fifth International Workshop on multiple endocrine neoplasia. Stockholm Archipelago, Sweden, June 29-July 2, 1994.
20. Hellmann P, Skogseid B, Oberg K, Juhlin C, Akerström G, Rastad J. Primary and reoperative parathyroid operations in hyperparathyroidism of multiple endocrine neoplasia type 1. Surgery. 1998;124(6):993-9, http://dx.doi.org/10.1016/S0039-6060(98)70040-6.
21. Dotzenrath C, Cupisti K, Goretzki PE, Yang Q, Simon D, Ohmann C, et al. Long-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine neoplasia types I and IIa: is a more or less extended operation essential? Eur J Surg. 2001;167(3):173-78, http://dx.doi.org/10.1080/110241501750099294.
22. Elaraj DM, Skarulis MC, Libutti SK, Norton JA, Bartlett DL, Pingpank JF, et al. Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Surgery. 2003;134(6):858-65, http://dx.doi.org/10.1016/S0039-6060(03)00406-9.
23. Edis AJ, Van Heerden JA, Scholz DA. Results of sub-total parathyroidectomy for primary chief cell hyperplasia. Surgery. 1979;86:462-9.
24. Prinz RA, Gamvros OP, Sellu D, Lynn JA. Subtotal parathyroidectomy for primary chief cell hyperplasia of the multiple endocrine neoplasia type 1 syndrome. Surgery. 1981;193(1):26-9.
25. Van Heerden JA, Kent RB, Sizemore GW, Grant CS, ReMine WH. Primary hyperparathyroidism in patients with multiple endocrine neoplasia syndromes. Surgical experience. Arch. Surg. 1983;118(5):533-6.
26. Goretzi PE, Dotzenrath C, Roeher HD. Management of primary hyperparathyroidism caused by multiglandular disease. World J Surg. 1991;15(6):693-7, http://dx.doi.org/10.1007/BF01665302.
27. Thompson NW, Sandelin K. Technical considerations in the surgical management of primary hyperparathyroidism caused by multiple gland disease (hyperplasia). Acta Chir. Austriaca. 1994;26(Suppl. 112):16-9.
28. Grant CS, Weaver A. Treatment of primary parathyroid hyperplasia: representative experience at Mayo Clinic. Acta Chir. Austriaca. 1994;26 (Suppl. 112):41-4.
29. Hubbard JGH, Sebag F, Maweja S, Henry JF. Subtotal parathyroidectomy as an adequate treatment for primary hyperparathyroidism in multiple endocrine neoplasia type 1. Arch Surg. 2006;141(3):235-9, http://dx.doi.org/10.1001/archsurg.141.3.235.
30. Sonoda T, Ohkawa T, Takeuchi M, Yachiku S. Successful parathyroid preservation: experimental study. Surgery. 1968;64(4):791-5.
31. Wells SA Jr, Farndon JR, Dale JK, Leight GS, Dilley WG. Long term evaluation of patients with primary parathyroid hyperplasia managed by total parathyroidectomy and heterotopic autotransplantation. Ann Surg. 1980;192(4):451-8, http://dx.doi.org/10.1097/00000658-198010000-00003.
32. Wagner PK, Seesko HG, Rothmund M. Replantation of cryopreserved human parathyroid tissue. World J Surg. 1991;15(6):751-5, http://dx.doi.org/10.1007/BF01665310.
33. Feldman AL, Sharaf RN, Skarulis MC, Bartlett DL, Libutti SK, Weinstein LS, et al. Results of heterotopic parathyroid autotransplantation: a 13-year experience. Surgery. 1999;126:1042-48, http://dx.doi.org/10.1067/msy.2099.101580.
34. Barnett HF, Thompson BW, Barbour GL. Parathyroid autotransplantation. Arch Surg. 1977;112(4):373-9, http://dx.doi.org/10.1001/archsurg. 1977.013700 40025004.
35. Dralle H, Sheuemann GFW. How to handle the parathyroid glands in multiple endocrine neoplasia type 1 (MEN-1) and type 2 (MEN-2)? Surgical approach to uniglandular vs multiglandular disease in hereditary primary hyperparathyroidism. Acta Chir Austriaca. 1994;26 (Suppl. 112):35-8.
36. Malmaeus J, Benson L, Johansson H, Ljunghall S, Rastad J, Akerström G, et al. Parathyroid surgery in the multiple endocrine neoplasia type 1 syndrome: choice of surgical procedure. World J Surg. 1986;10(4):668-72, http://dx.doi.org/10.1007/BF01655552.
37. Arnalsteen L, Quievreux JL, Huglo D, Pattou F, Carnaille B, Proye C. Reoperation for persistent or recurrent primary hyperparathyroidism. Seventy-seven cases among 1888 operated patients. Ann Chir. 2004;129(4):224-31.
38. Mariette C, Pellissier L, Combemale F, Quievreux JL, Carnaille B, Proye C. Reoperation for persistent or recurrent primary hyperparathyroidism. Langenbecks Arch Surg. 1998;383(2):174-9.
39. Matsuoka S, Tominaga Y, Sato T, Uno N, Goto N, Katayama A, Uchida K, et al. Recurrent renal hyperparathyroidism caused by parathyromatosis. World J Surg. 2007;31(2):299-305, http://dx.doi.org/10.1007/s00268-006-0391-z.
40. Metz DC, Jensen RT, Bale A, Skarulis MC, Eastman RC, Nieman L, et al. Multiple endocrine neoplasia type 1. In: Bilezikian JP, Marcus R, Levine MA. The parathyroids. Basic and clinical concepts. New York: Raven Press; 1994. pp.591-646.
41. Tonelli F, Amorosi A, Tommasi MS, et al. Fisiopatologia e diagnosi dell'iperparatiroidismo. Atti 92° Congr. SIC; Roma, 21-25 ottobre 1990; Luigi Pozzi srl ed. Roma.
42. Tonelli F, Spini S, Tommasi M, Gabbrielli G, Amorosi A, Brocchi A, et al. Intraoperative parathormone measurement in patients with multiple endocrine neoplasia type 1 syndrome and hyperparathyroidism. World J Surg. 2000;24(5):556-63, http://dx.doi.org/10.1007/s00268 9910091.
43. Kivlen MH, Bartlett DL, Libutti SK, Skarulis MC, Marx SJ, Simonds WF, et al. Reoperation for hyperparathyroidism in multiple endocrine neoplasia type 1. Surgery. 2001;130(6):991-8, http://dx.doi.org/10.1067/msy.2001.118379.
44. Clerici T, Brandle M, Lange J, Doherty GM, Gauger PG. Impact of intraoperative parathyroid hormone monitoring on the prediction of multiglandular parathyroid disease. World J Surg. 2004;28(2):187-92, http://dx.doi.org/10.1007/s00268-003-7255-6.
45. Jaskowiak NT, Sugg SL, Helke J, Koka MR, Kaplan EL. Pitfalls of intraoperative rapid parathyroid hormone monitoring and gamma probe localization in surgery for primary hyperparathyroidism. Arch Surg. 2002;137(6):659-68, http://dx.doi.org/10.1001/archsurg.137.6.659.
46. Thompson GB, Grant CS, Perrier ND, Harman R, Hodgson SF, Ilstrup D, et al. Reoperative parathyroid surgery in the era of sestamibi scanning and intraoperative parathyroid hormone monitoring. Arch Surg. 1999;134(7):699-705, http://dx.doi.org/10.1001/archsurg.134.7.699.
47. Knudsen L, Brandi L, Daugaard H, Olgaard K, Lockwood K. Five to 19 years follow-up after total parathyroidectomy and autotransplantation of parathyroid tissue: evaluation of parathyroid function by use of ischaemic blockade manoeuvre. Scand J Clin Invest. 1996;56(1):47-50, http://dx.doi.org/10.3109/00365519609088587.
48. Silverberg SJ, Bone HG 3rd, Marriott TB, Locker FG, Thys-Jacobs S, Dziem Get al. Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism. N Engl J Med. 1997;337(21):1506-10, http://dx.doi.org/10.1056/NEJM199711203372104.
49. Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med. 2004;350(15):1516-25, http://dx.doi.org/10.1056/NEJMoa031633.